NCT01993420View on ClinicalTrials.gov

A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Atopic Dermatitis
Interventions
DRUG

DRM02

OTHER

Vehicle

Trial Locations (2)

J2B5L4

Clinique Médicale Dr Isabelle Delorme, Drummondville

H2K 4L5

Innovaderm Research, Inc, Montreal

Sponsors

Lead Sponsor

Dermira, Inc.
All Listed Sponsors
lead

Dermira, Inc.

INDUSTRY

NCT01993420 - A Safety and Efficacy of DRM02 in Subjects With Atopic Dermatitis | Biotech Hunter | Biotech Hunter